HCA Healthcare, Inc. $HCA Shares Sold by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 16.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 88,410 shares of the company’s stock after selling 17,374 shares during the period. Wedge Capital Management L L P NC’s holdings in HCA Healthcare were worth $37,680,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of HCA. Abound Wealth Management lifted its position in shares of HCA Healthcare by 28.0% during the third quarter. Abound Wealth Management now owns 119 shares of the company’s stock worth $51,000 after purchasing an additional 26 shares during the last quarter. ORG Partners LLC increased its holdings in shares of HCA Healthcare by 27.9% in the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock valued at $55,000 after acquiring an additional 31 shares during the last quarter. Glenview Trust co lifted its stake in HCA Healthcare by 2.3% during the first quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after purchasing an additional 32 shares during the last quarter. Sivia Capital Partners LLC increased its stake in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the last quarter. Finally, Claret Asset Management Corp boosted its holdings in shares of HCA Healthcare by 5.9% in the 2nd quarter. Claret Asset Management Corp now owns 614 shares of the company’s stock valued at $235,000 after buying an additional 34 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 1.3%

HCA Healthcare stock opened at $472.69 on Friday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $520.00. The stock has a market cap of $107.87 billion, a price-to-earnings ratio of 18.27, a PEG ratio of 1.40 and a beta of 1.36. The company’s 50-day moving average price is $470.12 and its two-hundred day moving average price is $417.03.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the previous year, the company earned $4.90 earnings per share. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be given a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Analyst Ratings Changes

A number of equities analysts have commented on the company. UBS Group lifted their target price on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Truist Financial upped their price objective on HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Raymond James Financial set a $525.00 price target on shares of HCA Healthcare in a report on Monday, October 27th. Stephens lifted their price objective on shares of HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. Finally, TD Cowen raised their price target on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $479.00.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.